(KDLY) Kindly MD Common Stock - Ratings and Ratios

Kindly MD, Inc. operates at the intersection of healthcare delivery and data-driven insights, offering a comprehensive suite of medical and behavioral health services. The company provides specialty outpatient care on a subscription and fee-for-service model, aiming to complement traditional healthcare systems. Its clinical services include chronic pain management, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel health, and hormone therapy. Beyond clinical services, the company engages in data collection and research, digital marketing campaigns, and the retail sale of healthcare products through both physical clinics and online platforms.

Formerly known as Utah Therapeutic Health Center, LLC, the company rebranded as Kindly MD, Inc. in March 2022 to reflect its expanded scope and mission. Incorporated in 2019 and headquartered in Salt Lake City, Utah, Kindly MD, Inc. has established itself as a multi-faceted healthcare provider with a focus on integrated care and patient-centric solutions. The companys approach combines medical and behavioral health services, emphasizing a holistic model of care.

Ticker Symbol: KDLY (NASDAQ) represents the companys common stock, classified under the Health Care Services sub-industry. With a market capitalization of $7.55 million, Kindly MD, Inc. operates with a price-to-book ratio of 1.72 and a price-to-sales ratio of 2.44, reflecting its current valuation metrics. The companys return on equity stands at -84.41%, indicating significant challenges in profitability. Its forward and trailing P/E ratios are currently undefined, as the company has not reported positive earnings.

From a technical standpoint, KDLYs stock price of $1.42 is below its 20-day ($2.09) and 50-day ($1.65) moving averages, signaling bearish momentum. The 200-day moving average of $1.65 further underscores the stocks recent downward trajectory. Average trading volume over the past 20 days is 171,600 shares, with an average true range (ATR) of 0.35, indicating moderate volatility. The stocks relative strength index (RSI) is not provided but would be critical in assessing overbought or oversold conditions.

3-Month Forecast: Based on the convergence of technical and fundamental data, KDLY is likely to face continued pressure in the near term. The stocks position below key moving averages suggests bearish sentiment, while the negative return on equity raises concerns about profitability. However, the low price-to-sales ratio of 2.44 may indicate undervaluation, potentially attracting value investors. The companys ability to expand its service offerings and improve operational efficiency will be critical in determining its trajectory. Short-term price targets could range between $1.10 and $1.80, depending on market sentiment and earnings visibility.